Resistance to bacteriocins produced by Gram-positive bacteria.

  title={Resistance to bacteriocins produced by Gram-positive bacteria.},
  author={M. do C. de F. Bastos and Marcus L{\'i}vio Varella Coelho and Olinda Cabral Silva Santos},
  volume={161 Pt 4},
Bacteriocins are prokaryotic proteins or peptides with antimicrobial activity. Most of them exhibit a broad spectrum of activity, inhibiting micro-organisms belonging to different genera and species, including many bacterial pathogens which cause human, animal or plant infections. Therefore, these substances have potential biotechnological applications in either food preservation or prevention and control of bacterial infectious diseases. However, there is concern that continuous exposure of… 

Figures and Tables from this paper

Bacteriocins, Antimicrobial Peptides from Bacterial Origin: Overview of Their Biology and Their Impact against Multidrug-Resistant Bacteria

An updated global report on the biology of bacteriocins produced by GPB and GNB, as well as their antibacterial activity against relevant bacterial pathogens, and especially against multidrug-resistant bacteria is presented.

Study of the Effect of Bacteriocin-producing Bacillus subtilis Strains on Beta-lactamase-producing Pathogenic Bacteria

  • C. Ghazaei
  • Biology, Medicine
    Journal of Clinical Research in Paramedical Sciences
  • 2022
B bacteriocin can become a potential alternative to standard available medicines against antimicrobial-resistant pathogenic bacteria because of their significant inhibitory activity against the tested pathogens compared to the standard antibiotics.

Staphylococcal-Produced Bacteriocins and Antimicrobial Peptides: Their Potential as Alternative Treatments for Staphylococcus aureus Infections

The ability of these staphylococcal-derived antimicrobial peptides to target biofilm formation and their novel mechanisms of action with efficacy against antibiotic-resistant bacteria make them strong candidates as novel therapeutic antimicrobials.

Bacteriocins from the rhizosphere microbiome – from an agriculture perspective

Th Thuricin 17 (Th17) is the only bacteriocin studied extensively for plant growth promotion, including at the molecular level, which functions as a bacterial signal compound, promoting plant growth in legumes and non-legumes.

Bacteriocins in the Era of Antibiotic Resistance: Rising to the Challenge

Bacteriocins are potent small antimicrobial peptides synthetized by certain bacteria that may be appointed as alternatives to traditional antibiotics, and their potential as antimicrobial therapeutics for infections produced mainly by resistant pathogens is discussed.

Combined Action of Antibiotics and Bacteriocins against Vancomycin-Resistant Enterococci

The data obtained indicate that the selected bacteriocins can be used to control VRE in the food industry or even as an alternative treatment to combat infections with antibiotic-resistant bacteria.

Screening for antimicrobial agents against the fish pathogens, Streptococcus agalactiae and Yersinia ruckeri, in fermented fruit and vegetables

This study searched for bacteria able to produce bacteriocins inhibiting the two fish pathogens Streptococcus agalactiae and Yersinia ruckeri in samples made from fermented fruit and vegetables by screening, using a method based on separating the fish pathogen and the samples in different layers on an agar plate.



Bacteriocins of gram-positive bacteria

In recent years, a group of antibacterial proteins produced by gram-positive bacteria have attracted great interest in their potential use as food preservatives and as antibacterial agents to combat

Ribosomally Synthesiszed Antimicrobial Peptides (Bacteriocins) in Lactic Acid Bacteria: A Review

A short outlook of the field of bacteriocins in Gram-positive bacteria with focus on lactic acid bacteria is given and includes recent findings.

The dlt Operon of Bacillus cereus Is Required for Resistance to Cationic Antimicrobial Peptides and for Virulence in Insects

It is suggested that the dlt operon protects B. cereus against insect humoral immune mediators, including hemolymph cationic AMPs, and may be critical for the establishment of lethal septicemia in insects and in nosocomial infections in humans.

Bacteriocins — a viable alternative to antibiotics?

Although the application of specific bacteriocins might be curtailed by the development of resistance, an understanding of the mechanisms by which such resistance could emerge will enable researchers to develop strategies to minimize this potential problem.

Staphylococcal antimicrobial peptides: relevant properties and potential biotechnological applications.

Staphylococcins may be used, solely or in combination with other chemical agents, to avoid food contamination or spoilage and to prevent or treat bacterial infectious diseases, and can result in synergistic inhibition.

Lysostaphin: A Staphylococcal Bacteriolysin with Potential Clinical Applications

In vitro and in vivo studies performed with lysostaphin have shown that thisStaphylococcin has potential to be used, solely or in combination with other antibacterial agents, to prevent or treat bacterial staphylococcal infectious diseases.

Common Mechanistic Action of Bacteriocins from Lactic Acid Bacteria

It is suggested that the bacteriocins of lactic acid bacteria share a common mechanism, the depletion of PMF, as has been shown for nisin.

Frequency of Bacteriocin Resistance Development and Associated Fitness Costs in Listeria monocytogenes

While considerable strain-specific variations in the frequency of resistance development and associated fitness costs were observed, the influence of environmental stress seemed to be bacteriocin specific.

Lacticin 3147--biosynthesis, molecular analysis, immunity, bioengineering and applications.

The merits of employing lacticin 3147 to control spoilage microbes as well as its potential in the elimination of food, human and veterinary pathogens have also been highlighted.

The dlt operon confers resistance to cationic antimicrobial peptides in Clostridium difficile.

The data indicate that the dlt operon is necessary for full resistance of C. difficile to nisin, gallidermin, polymyxin B and vancomycin, and the d-alanylation of teichoic acids provides protection against antimicrobial peptides that may be essential for growth of the bacterium in the host.